NCT03603301

Brief Summary

The investigators will re-investigate 150 children studied extensively in the past. 100 of these children were born to mothers prescribed methadone during their pregnancy because of opiate dependency, and 50 were comparison children who were not exposed to drugs. These children were investigated when they were newborn babies, and again when they were six months old, and a quarter of the drug-exposed babies had problems with their eyesight, whilst very few of the comparison children has eyesight problems. The investigators would like to see whether the eyesight problems are still present in the children now that they are older. Because they are older, more detailed testing can be undertaken which will help to understand how drug exposure in the womb may have affected their eyesight. The investigators will recruit new, comparison children to the study to match the number of comparison children with the number of drug-exposed children. The findings will be relevant and important when advising mothers on drug use - both prescribed and illicit - when they are pregnant.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

July 1, 2017

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

July 27, 2018

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

August 1, 2018

Status Verified

July 1, 2018

Enrollment Period

1.6 years

First QC Date

March 22, 2017

Last Update Submit

July 30, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • presence of strabismus, nystagmus, reduced acuity, significant refractive error

    natural history of visual abnormalities following in utero exposure to methadone +/- other drugs

    2 years

Secondary Outcomes (1)

  • correlation of abnormality or normality with prenatal drug exposure

    2 years

Eligibility Criteria

Age7 Years - 10 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

100 drug-exposed neonates and 50 comparison infants, all born between 13/08/2008 and 30/04/2009 at the Princess Royal Maternity in Glasgow, previously recruited to the VIDI study; an additional 50 classroom comparison children.

You may qualify if:

  • cases: born to opioid-dependent mothers prescribed substitute methadone during pregnancy and delivered after 36 completed weeks' gestation.
  • comparisons: healthy, non drug-exposed infants delivered within the same maternity unit, matched for gestation, birthweight ± 250g and Carstairs deprivation score ± 1; attempted match for smoking

You may not qualify if:

  • congenital ocular abnormality; significant neonatal illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Clinical Research Facility (CRF), Queen Elizabeth University Hospital

Glasgow, G51 4TF, United Kingdom

Location

Related Publications (1)

  • Hamilton R, Mulvihill A, Butler L, Chow A, Irving E, McCulloch DL, McNeil A, Michael K, Spowart KM, Waterson-Wilson J, Mactier H. Impaired vision in children prenatally exposed to methadone: an observational cohort study. Eye (Lond). 2024 Jan;38(1):118-126. doi: 10.1038/s41433-023-02644-3. Epub 2023 Jul 4.

MeSH Terms

Conditions

Vision DisordersStrabismusNystagmus, Pathologic

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOcular Motility DisordersCranial Nerve Diseases

Study Officials

  • Ruth Hamilton, PhD

    NHS Greater Glasgow & Clyde

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2017

First Posted

July 27, 2018

Study Start

July 1, 2017

Primary Completion

February 1, 2019

Study Completion

June 1, 2020

Last Updated

August 1, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations